PAR paradigm biopharmaceuticals limited..

Ann: Loyalty and Piggyback Options Program, page-495

  1. 3,874 Posts.
    lightbulb Created with Sketch. 142
    Bedger, you make it sound adversarial, when we are the company even if we don't control it.

    If an attractive funding arrangement is announced in the next few months and the shares re-rate as one would expect - shareholders win and we, the company, get more funding from the exercise. Double win.

    Suspect some buyers see that with fast tracked Ph3 underway, there should be a few funding options on the table awaiting finalisation.

    Not surprised there are some excited buyers lining up.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.0¢
Change
-0.015(4.48%)
Mkt cap ! $124.6M
Open High Low Value Volume
33.5¢ 34.0¢ 31.5¢ $215.7K 663.5K

Buyers (Bids)

No. Vol. Price($)
3 30081 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 10905 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.